1. Home
  2. |Insights
  3. |Antitrust in 2013: Litigating SEPs and FRAND Terms

Antitrust in 2013: Litigating SEPs and FRAND Terms

Event | 02.12.13, 12:00 AM UTC - 12:00 AM UTC

The FTC’s recent settlement of its long-standing antitrust investigation of Google answered some questions about the assertion of standard-essential patents (SEPs) encumbered by commitments to license on fair, reasonable, and nondiscriminatory (FRAND) terms.  But it left open many important questions at the intersection of IP rights and antitrust law for companies involved in innovating, implementing, and litigating emerging technology.

This webinar will examine:

  • After FTC/Google, what key steps must SEP holders and implementers take to negotiate licenses on FRAND terms before litigating to enjoin product sales and imports?
  • In litigation, which test will be used to determine whether proposed SEP licensing rates and other terms are FRAND?
  • How will antitrust litigation enforcement against standard-setting organizations (SSOs) and their members change?
  • Will the new SEP “rules of the road” have any effect on the licensing and enforcement of non-standard-essential IP?

For more information, please visit these areas: Litigation and Trial

Participants

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures. 

View All Insights